HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Brown, A. K. Articles by Besra, G. S. Search for Related Content PubMed PubMed Citation Articles by Brown, A. K. Articles by Besra, G. S. Agricola Articles by Brown, A. K. Articles by Besra, G. S.

Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II

School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

Correspondence
Gurdyal S. Besra
g.besra{at}bham.ac.uk

Flavonoids comprise a large group of bioactive polyphenolic plant secondary metabolites. Several of these possess potent in vivo activity against Escherichia coli and Plasmodium falciparum, targeting enzymes involved in fatty acid biosynthesis, such as enoyl-ACP-reductase, β-ketoacyl-ACP reductase and β-hydroxyacyl-ACP dehydratase. Herein, we report that butein, isoliquirtigenin, 2,2',4'-trihydroxychalcone and fisetin inhibit the growth of Mycobacterium bovis BCG. Furthermore, in vitro inhibition of the mycolic-acid-producing fatty acid synthase II (FAS-II) of Mycobacterium smegmatis suggests a mode of action related to those observed in E. coli and P. falciparum. Through a bioinformatic approach, we have established the product of Rv0636 as a candidate for the unknown mycobacterial dehydratase, and its overexpression in M. bovis BCG conferred resistance to growth inhibition by butein and isoliquirtigenin, and relieved inhibition of fatty acid and mycolic acid biosynthesis in vivo. Furthermore, after overexpression of Rv0636 in M. smegmatis, FAS-II was less sensitive to these inhibitors in vitro. Overall, the data suggest that these flavonoids are inhibitors of mycobacterial FAS-II and in particular Rv0636, which represents a strong candidate for the β-hydroxyacyl-ACP dehydratase enzyme of M. tuberculosis FAS-II.

This article has been cited by other articles:

				V. Bhowruth, A. K. Brown, and G. S. Besra Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636 Microbiology, July 1, 2008; 154(7): 1866 - 1875. [Abstract] [Full Text] [PDF]

				A. K. Brown, A. Bhatt, A. Singh, E. Saparia, A. F. Evans, and G. S. Besra Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex Microbiology, December 1, 2007; 153(12): 4166 - 4173. [Abstract] [Full Text] [PDF]